cancer clinical trials in reading, PA
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
|
Reading Hospital and Medical Center
Trial Locations Reading Hospital and Medical Center Saint Joseph Medical Center Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
|
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Esophageal Cancer
|
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Breast Cancer, Fatigue, Sleep Disorders
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
|
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Lung Cancer
|
Saint Joseph Medical Center
Reading, Pennsylvania 19605 Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Multiple Myeloma, Plasma Cell Neoplasm
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
|
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Endometrial Cancer, Fatigue, Neurotoxicity
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Breast Cancer
|
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Endometrial Cancer
|
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
|
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Prostate Cancer
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
|
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Endometrial Cancer
|
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Ovarian Cancer, Sarcoma
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Adenocarcinoma of the Lung, Bronchoalveolar Cell Lung Cancer, Large Cell Lung Cancer, Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
|
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Head and Neck Cancer
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
|
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Lung Cancer
|
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Cervical Cancer
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Recurrent Uterine Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma, Stage IIIC Uterine Sarcoma, Stage IVA Uterine Sarcoma, Stage IVB Uterine Sarcoma, Uterine Leiomyosarcoma
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Adenocarcinoma of the Pancreas, Stage I Pancreatic Cancer, Stage II Pancreatic Cancer
|
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Brain and Central Nervous System Tumors
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
|
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Breast Cancer
|
Saint Joseph Medical Center
Reading, Pennsylvania 19605 Breast Cancer
|
St. Joseph Medical Center
Trial Locations St. Joseph Medical Center McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center Lung Cancer
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Stage IB Esophageal Cancer, Stage IIA Esophageal Cancer, Stage IIB Esophageal Cancer, Stage IIIA Esophageal Cancer, Stage IIIB Esophageal Cancer
|
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Lymphoma
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
|
Reading Hospital and Medical Center
Trial Locations Reading Hospital and Medical Center Saint Joseph Medical Center Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
|
Reading Hospital and Medical Center
Trial Locations Reading Hospital and Medical Center Saint Joseph Medical Center Breast Cancer
|
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Cervical Cancer, Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Sexuality and Reproductive Issues
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Refractory Anemia With Excess Blasts, Secondary Myelodysplastic Syndromes
|
Reading Hospital and Medical Center
Trial Locations Reading Hospital and Medical Center Saint Joseph Medical Center Breast Cancer
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Recurrent Uterine Sarcoma, Uterine Leiomyosarcoma
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Cervical Cancer, Endometrial Cancer, Gastrointestinal Complications, Perioperative/Postoperative Complications, Radiation Toxicity, Urinary Complications, Urinary Tract Toxicity
|
Investigational Site Number 840062
Reading, Pennsylvania 19611 Rheumatoid Arthritis
|
Investigational Site Number 840062
Reading, Pennsylvania 19611 Rheumatoid Arthritis
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Brain and Central Nervous System Tumors
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Lung Cancer
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Prostate Cancer
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Metastatic Cancer
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Metastatic Cancer
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Sarcoma
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Breast Cancer
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Breast Cancer
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Breast Cancer, Metastatic Cancer, Pain, Prostate Cancer
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Head and Neck Cancer
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Prostate Cancer
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Breast Cancer
|
Reading Hospital and Medical Center
Reading, Pennsylvania 19612-6052 Brain and Central Nervous System Tumors
|